Extendicare Inc.
EXE.TOTSXHealthcare● Active
$32.85
$-0.29(-0.88%)
Market Cap$3.1B
P/E Ratio—
52W High$35.62
52W Low$12.12
Extendicare Inc.（EXE.TO）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · EXE.TO · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $0.10B | $0.08B | $0.03B | $0.07B | $0.01B |
| Depreciation & Amort. | $0.04B | $0.03B | $0.03B | $0.03B | $0.04B |
| Stock-Based Comp. | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Change in Working Capital | $0.06B | $0.02B | ($0.04B) | $0.05B | $0.01B |
| Net Cash from Operations | $0.17B | $0.14B | $0.02B | $0.10B | $0.06B |
| Investing Activities | |||||
| Capital Expenditure | ($0.10B) | ($0.04B) | ($0.13B) | ($0.10B) | ($0.07B) |
| Purchases of Investments | ($0.00B) | $0.00B | $0.00B | $0.00B | $0.00B |
| Sales of Investments | $0.06B | $0.03B | $0.00B | $0.00B | $0.00B |
| Net Cash from Investing | ($0.12B) | ($0.01B) | ($0.08B) | $0.16B | ($0.06B) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | $0.00B | ($0.01B) | ($0.04B) | $0.00B |
| Dividends Paid | ($0.04B) | ($0.04B) | ($0.04B) | ($0.04B) | ($0.04B) |
| Debt Issued / Repaid | $0.03B | ($0.04B) | $0.02B | ($0.11B) | ($0.03B) |
| Net Cash from Financing | $0.18B | ($0.09B) | ($0.03B) | ($0.19B) | ($0.07B) |
| Free Cash Flow | |||||
| Free Cash Flow | $0.06B | $0.10B | ($0.11B) | ($0.00B) | ($0.01B) |
| FCF Margin %(computed) | 3.82% | 6.94% | -8.13% | -0.23% | -0.52% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · CAD · B
深入了解Extendicare Inc.
关于Extendicare Inc.（EXE.TO）现金流量表
Extendicare Inc. 2025财年经营活动现金流$0.17B，自由现金流$0.06B（FCF利润率3.82%），资本支出($0.10B)。
常见问题
EXE.TO · 4 问Extendicare Inc. 2025财年自由现金流$0.06B，同比down37.7%。
EXE.TO free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10